[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352625-105":59,"doc-detail-352625-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","negative-control-anchored-urinary-microbiome-profiling-with-absolute-16s-quantification-a-pilot-study-in-newly-diagnosed-treatment-naive-bladder-cancer-and-healthy-individuals","Negative-control-anchored urinary microbiome profiling with absolute 16S quantification - a pilot study in newly diagnosed, treatment-naive bladder cancer and healthy individuals","","16S rRNA amplicon sequencing has challenged the idea of urine sterility, but urine’s low biomass makes community profiles vulnerable to reagent and processing background signals. This pilot study applies a negative-control-anchored workflow combining absolute 16S rRNA gene quantification with urinary 16S amplicon sequencing. Using bacterial load as a biomass-aware quality gate, samples with low read counts are objectively excluded. In midstream urine from healthy volunteers and newly diagnosed, treatment-naive bladder cancer patients, bacterial load was lower in cancer cases, though not significant in this underpowered cohort.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/negative-control-anchored-urinary-microbiome-profiling-with-absolute-16s-quantification-a-pilot-study-in-newly-diagnosed-treatment-naive-bladder-cancer-and-healthy-individuals/352625/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/negative-control-anchored-urinary-microbiome-profiling-with-absolute-16s-quantification-a-pilot-study-in-newly-diagnosed-treatment-naive-bladder-cancer-and-healthy-individuals/352625.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was a negative-control-anchored workflow needed for urine microbiome profiling?","Question",{"text":112,"@type":113},"Urine is a low-biomass specimen, so apparent community profiles can be heavily influenced by background signals from reagents and processing. A negative-control-anchored approach improves interpretability by grounding exclusion criteria in controls.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does bacterial load support quality control in this study?",{"text":117,"@type":113},"Absolute 16S rRNA gene quantification provides a biomass-aware quality control gate. It defines low-biomass thresholds and objective exclusion criteria to reduce background-driven over-interpretation.",{"name":119,"@type":110,"acceptedAnswer":120},"What sample types and study groups were compared?",{"text":121,"@type":113},"Midstream urine collected prior to instrumentation was compared between healthy volunteers and newly diagnosed, treatment-naive bladder cancer patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352625,1790620879,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Negative-control-anchored urinary microbiome profiling with absolute 16S quantification: a pilot study in newly diagnosed, treatment-naive bladder cancer and healthy individuals  \nTomaž Accetto1 ,‡, Katja Strašek Smrdel2 ,‡, Milena Taskovska3,4 , Marjanca Starˇciˇc Erjavec1 , Tomaž Smrkolj3,4 , Katja Seme2 , Mateja Erdani Kreft 5 , *  \n1 Department of Microbiology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia  \n2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia  \n3 Clinical department of Urology, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia  \n4 Chair of Surgery, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia  \n5 Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia  \n∗ Corresponding author. Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000 Ljubljana, +386 1 543 76 85. [E-mail:](E-mail: mateja.erdani@mf.uni-lj.si)[ mateja.erdani@mf.uni-lj.si](E-mail: mateja.erdani@mf.uni-lj.si)  \n[Editor:](Editor: Clare Taylor)[ Clare Taylor](Editor: Clare Taylor)  \n‡These authors contributed equally to this work and share first authorship.  \nAbstract  \nRecent studies utilizing 16S rRNA amplicon sequencing have challenged the notion of urine sterility, yet urine is a low-biomass specimen in which apparent community profiles can be strongly influenced by background signal from reagents and processing. To address this interpretability gap, we integrate culture-independent absolute 16S rRNA gene quantification with urinary 16S amplicon sequencing in a negative-control-anchored workflow. Bacterial load provides a biomass-aware quality control gate that defines interpretable low-biomass thresholds and objective exclusion criteria. As a pilot application, we compared midstream urine collected prior to instrumentation from healthy volunteers and newly diagnosed bladder cancer (BC) patients, quality filtering retained 29 controls and 5 BC cases. Samples > 106 copies/ml typically produced > 10 000 reads; near 105 copies/ml read counts dropped sharply yet remained distinguishable from background. Thirteen negative controls (V3–V4 PCR and stabilization buffer; median 90, mean 124 reads) supported excluding samples with \u003C 1000 reads. Median bacterial load was lower in BC than in controls (7.0 × 103 vs 1.07 × 106 copies/ml), although not significant in this underpowered cohort (P = 0.07). This cohort-size-independent framework enables load-based triage for sequencing, reduces backgrounddriven over-interpretation in low-biomass urine datasets, and supports modeling bacterial load as a covariate or stratifier in future studies of the bladder cancer microbiome.  \nKeywords bladder cancer, midstream urine, microbiota, urinary tract infection, next-generation sequencing, nonmetric multidimensional scaling, absolute quantification, negative controls, low biomass  \nAbbreviations  \nBC: Bladder Cancer  \nUTI: Urinary Tract Infection  \nrRNA: Ribosomal RNA  \nDNA: Deoxyribonucleic Acid  \nOTU: Operational Taxonomic Unit  \nPCR: Polymerase Chain Reaction  \nNGS: Next-Generation Sequencing  \nNMDS: Nonmetric Multidimensional Scaling  \nIntroduction  \nTraditionally, the urine has been considered sterile, and the fastgrowing bacteria like Escherichia coli were only cultivated from it in connection with urinary tract infections (UTIs) (Whiteside et al. 2015). This was challenged with culture-independent 16S rRNA amplicon sequencing in the past decade which readily detected bacterial communities (Whiteside et al. 2015) . This gave incentive to develop more sophisticated culturing procedures (the enhanced quantitative urine culture) (Hilt et al. 2020), which largely  \nReceived: 10 October 2025 . Revised: 19 January 2026 . Accepted: 6 February 2026  \n© The Author(s) 2026 . Published by Oxford University Press on behalf of FEMS. This is an Open Access a","cbCaiup2Y8b3mFeB","https://ap.wps.com/l/cbCaiup2Y8b3mFeB","pdf",987431,"English","# Abstract\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"Why was a negative-control-anchored workflow needed for urine microbiome profiling?\",\"answer\":\"Urine is a low-biomass specimen, so apparent community profiles can be heavily influenced by background signals from reagents and processing. A negative-control-anchored approach improves interpretability by grounding exclusion criteria in controls.\"},{\"question\":\"How does bacterial load support quality control in this study?\",\"answer\":\"Absolute 16S rRNA gene quantification provides a biomass-aware quality control gate. It defines low-biomass thresholds and objective exclusion criteria to reduce background-driven over-interpretation.\"},{\"question\":\"What sample types and study groups were compared?\",\"answer\":\"Midstream urine collected prior to instrumentation was compared between healthy volunteers and newly diagnosed, treatment-naive bladder cancer patients.\"}]","Negative-control-anchored urinary microbiome profiling with absolute 16S quantification - a pilot study in newly diagnosed, treatment-naive bladder cancer and healthy individuals | PDF",1790100526,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a39bd814932ffdc1d7cbe42413d079ef.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df7f8fa1dedbe37f3d744cec6b8379be.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e977bfda0edd88a96dcedf423d142a33.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a90556ecbbbc0c822d8b0ec3e5eae5eb.webp",980,1287]